Justin Bowers
Stock Analyst at Deutsche Bank
(1.86)
# 3,115
Out of 5,182 analysts
41
Total ratings
37.5%
Success rate
4.36%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $370 → $330 | $299.79 | +10.08% | 5 | Mar 25, 2026 | |
| MEDP Medpace Holdings | Maintains: Hold | $270 → $430 | $421.37 | +2.05% | 3 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $163.84 | +61.74% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $10.60 | +116.98% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $22.67 | +27.92% | 1 | Aug 19, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $22.28 | +12.21% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $118.29 | +31.03% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $468.04 | +30.33% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $55.11 | +48.79% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Maintains: Hold | $23 → $25 | $7.97 | +213.68% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $3.68 | +361.96% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $103.21 | +190.67% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $180.62 | +52.25% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $302.20 | -17.27% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $171.23 | +69.36% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $16.45 | +179.64% | 5 | May 10, 2021 |
Waters
Mar 25, 2026
Maintains: Hold
Price Target: $370 → $330
Current: $299.79
Upside: +10.08%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $270 → $430
Current: $421.37
Upside: +2.05%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $163.84
Upside: +61.74%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $10.60
Upside: +116.98%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $22.67
Upside: +27.92%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $22.28
Upside: +12.21%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $118.29
Upside: +31.03%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $468.04
Upside: +30.33%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $55.11
Upside: +48.79%
Avantor
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $7.97
Upside: +213.68%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $3.68
Upside: +361.96%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $103.21
Upside: +190.67%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $180.62
Upside: +52.25%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $302.20
Upside: -17.27%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $171.23
Upside: +69.36%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $16.45
Upside: +179.64%